We introduce: Dr. Hannah Scheiblich
Hannah Scheiblich and her group are investigating the role of microglia during neuroinflammation and their role in neurodegenerative diseases. Situated at the Institute of Clinical Chemistry and Clinical Pharmacology of the University Hospital Bonn, Scheiblich recently started her research group at the cluster of excellence.
The central nervous system (CNS) is prone to inflammation both during normal aging and during the development and progression of neurodegenerative diseases. The observed inflammatory events are mainly mediated by microglia, the brain’s specific immune cells. Microglia are highly dynamic and responsive cells that promptly respond to homeostatic changes. These changes may switch the function of microglia from housekeepers to adaptive responders executing an inflammatory response that, if persistent, causes chronic neuroinflammation and neuronal damage.
Hannah Scheiblich and her group are investigating the role of microglia during neuroinflammation and their role in neurodegenerative diseases. By combining biochemistry, cell biology, and systems biology approaches, the group aims to understand the molecular and cellular mechanisms by which neuroinflammation affects immune cell function and the progression of neurodegenerative diseases. "One of the key objectives of our lab will be to unravel the fundamental principles of microglia-neuron interaction and its role in aging and disease" Scheiblich states. The group intends to develop novel experimental approaches to reveal the molecular mechanisms through which microglia control and consolidate neuronal survival to slow the progression of neurodegenerative processes. In addition, the group is also interested in studying how microglia may play a role in other neuronal disorders.
Short biography
Hannah Scheiblich recieved her PhD from the University of Veterenary Medicine Hannover in 2015. After a research stay at the at the Medical Research Council – Toxicology Unit, at teh University of Leicester, England, Scheiblich joined the department of Neurodegenerative Diseases and Gerontopsychiatry at the University Hospital Bonn, as a postdoctoral research fellow and joined the Institute of Innate Immunity at the University Hospital Bonn in 2022. From May 2023, Hanna Scheiblich is heading a Junior Research Group at the Institute of Clinical Chemistry and Clinical Pharmacology of the University Hospital Bonn.
Contact
Hannah Scheiblich
Institute of Clinical Chemistry and Clinical Pharmacology
University Hospital Bonn
Venusberg Campis 1
53127 Bonn
email: hannah.scheiblich@ukbonn.de
